°Ç°�°úÁúº´6-24È£



Similar documents
제5호-9차

768 PUBLIC HEALTH WEEKLY REPORT, KCDC 있으며, 국제적 정보 공유 및 국내 수행 임상시험과 임상연구의 우수성을 홍보할 수 있는 기회를 마련할 수 있을 것이다. II. 몸 말 임상연구정보서비스시스템(CRIS)에는 임상연구의 종류 (중재연구,

편집순서 1 : 겉표지 학술연구용역사업최종결과보고서 과 국문과제명 제 영문과제명 명 주 의 ( 주의내용기재 ) 2 0 주관연구기관 : ( 글 14 point 고딕체 ) 질병관리본부 질병관리본부 - 1 -

012임수진

건강과질병-6권28호-color.indd

¿À¸®ÄÞ40

<30322EC6AFC1FD30342DC1A4B9AEC7F62E687770>

예방접종관리과

1..

590호(01-11)


건강과질병4-44호

노영남

건강과질병4-28호

¿À¸®ÄÞ38

관광정책-38호1부.indd

DBPIA-NURIMEDIA

Lumbar spine

부속

한국성인에서초기황반변성질환과 연관된위험요인연구

16(2)-7(p ).fm

00약제부봄호c03逞풚


3

∞«∞≠∞˙¡˙∫¥_4-5»£-3¬˜

달생산이 초산모 분만시간에 미치는 영향 Ⅰ. 서 론 Ⅱ. 연구대상 및 방법 達 은 23) 의 丹 溪 에 최초로 기 재된 처방으로, 에 복용하면 한 다하여 난산의 예방과 및, 등에 널리 활용되어 왔다. 達 은 이 毒 하고 는 甘 苦 하여 氣, 氣 寬,, 結 의 효능이 있

전립선암발생률추정과관련요인분석 : The Korean Cancer Prevention Study-II (KCPS-II)

DBPIA-NURIMEDIA

열린포항 12월호

<C0D3C7F6BCFA2E687770>

황지웅

YI Ggodme : The Lives and Diseases of Females during the Latter Half of the Joseon Dynasty as Reconstructed with Cases in Yeoksi Manpil (Stray Notes w

건강과질병4-42호-1

04_이근원_21~27.hwp

歯채민병.PDF

( )Jkstro011.hwp

Trd022.hwp

untitled

∞«∞≠∞˙¡˙∫¥_3-38»£-10¬˜

보건사회연구-25일수정

E-test 를이용한항진균제감수성검사 79 는 fluconazole의치료를받은환자에서더흔하며, amphotericin B에대한내성균도산발적으로보고되고있다 [1]. 따라서세균감염에서와마찬가지로진균감염에서도치료제의선택과내성균주의검출을위하여신뢰성있는항진균제감수성검사의필요성이

서론 34 2

03¹ü¼±±Ô

(Exposure) Exposure (Exposure Assesment) EMF Unknown to mechanism Health Effect (Effect) Unknown to mechanism Behavior pattern (Micro- Environment) Re

< D B4D9C3CAC1A120BCD2C7C1C6AEC4DCC5C3C6AEB7BBC1EEC0C720B3EBBEC8C0C720BDC3B7C2BAB8C1A4BFA120B4EBC7D120C0AFBFEBBCBA20C6F2B0A E687770>

,,,.,,,, (, 2013).,.,, (,, 2011). (, 2007;, 2008), (, 2005;,, 2007).,, (,, 2010;, 2010), (2012),,,.. (, 2011:,, 2012). (2007) 26%., (,,, 2011;, 2006;

DBPIA-NURIMEDIA

< B3E220BCF6C1B7B1B8BAB4C1F6C4A72D56312E687770>

Transcription:

K O R E A C E N T E R S F O R D I S E A S E C O N T R O L & P R E V E N T I O N PHWR Vol. 6 No. 24 www.cdc.go.kr 2013 6 14 6 24 ISSN: 2005-811X Animal bite cases in high-risk region of rabies, 2011-2012 CONTENTS

466 PUBLIC HEALTH WEEKLY REPORT, KCDC Figure 1. The map showing animal rabies outbreak regions across the natural barrier(yeongdong expressway) in 2012(black). High-risk and suspect-risk regions indicated to gray and light gray colors Figure 2. Number of animal bite and incidence of rabies cases reported in high-risk region of rabies in Korea, 2005-2012

www.cdc.go.kr 467 Table 1. The demographic characteristics of all the animal bite patients in high-risk region in Korea, 2011-2012

468 PUBLIC HEALTH WEEKLY REPORT, KCDC Table 2. Body site and animal species caused bite in high-risk region in Korea, 2011-2012 Table 3. Analysis of factors influencing prophylaxis and treatment in the cases after animal bites patients in 2011-2012 Table 4. Analysis of factors influencing prophylaxis and treatment in the cases after exposure category III to animal bites

www.cdc.go.kr 469 Figure 3. The number of cases of rabies virus infection in animals and incidence of animal biting between 2005 and 2012 in Gyeonggi, Gangwon provinces

470 PUBLIC HEALTH WEEKLY REPORT, KCDC Analysis of antifungal susceptibility testing of Candida isolates by revised CLSI and EUCAST method

www.cdc.go.kr 471 Table 1. Comparison of antifungal susceptibility testing method (CLSI and EUCAST method) of yeast species

472 PUBLIC HEALTH WEEKLY REPORT, KCDC Table 2. Distribution of yeasts recovered from clinical specimens during a year period(2011) Table 3. Source of clinical isolates of Candida species recovered from hospitals used for antifungal susceptibility testing

www.cdc.go.kr 주간 건강과 질병 473 Table 4. Antifungal susceptibilities of 1,582 clinical isolates of Candida species from Korea 마이카펀진에 대한 감수성은 99.5%(1,275/1,281), 99.8% EUCAST 시험법은 적용이 가능한 C. albicans, C. tropicalis (1,534/1,536) 및 99.6%(1,511/1,516)로 높았다. 및 C. parapsilosis의 경우 CLSI법과 비교하여 항진균제 총 1,582주를 대상으로 두 가지 방법에 의한 5가지 주요 감수성시험 결과 일치율이 높았으나 C. glabrata 등의 다른 항진균제에 대해 감수성 시험을 실시한 결과 각 항진균제에 균종에서 적용 기준이 없어 CLSI법과 범주 일치율을 비교 대한 MIC 범위는 Table 5와 같다. CLSI M27-A3법에 하기는 어려웠다. 의한 24시간 방법으로 판정한 칸디다 종의 암포테리신 B, 플루코나졸, 보리코나졸, 카스포펀진, 마이카펀진에 대한 Ⅲ. 맺는 말 MIC는 각각 0.03-4 mg/ml, 0.125-64 mg/ml, 0.03-16 mg/ml, 0.015-1 및 0.007-4 mg/ml이었다. EUCAST에 최근 CLSI에서는 항진균제 감수성 시험 결과 판정 기준을 의한 결과도 매우 유사하여 두 방법은 모든 항진균제 감수성 칸디다 종 별로 달리 적용하는 새로운 Clinical breakpoints 시험에서 높은 일치률(2배 희석배수 내)을 보였다. 그러나 (CBPs)를 발표하였다. CBP는 항진균제 치료 반응을 예측

474 PUBLIC HEALTH WEEKLY REPORT, KCDC Table 5. Antifungal MIC distribition of 1,582 clincial isolates of Candida species to amphotericin B, micafungin, caspofungin, vociconazole and fluconazole as determined with the 24-h CLSI and EUCAST methods

www.cdc.go.kr 475 World Blood Donor Day, 14 June 2013 Figure 1. The 10th anniversary banner of World Blood Donor Day(WBDD) 2013

476 PUBLIC HEALTH WEEKLY REPORT, KCDC (A) (B) (C) Figure 2. A: WBDD 2013 posters, B: The Global host for 2013-France posters, C: Korean red cross blood services invitation for WBDD 2013

www.cdc.go.kr 477 Current status of selected infectious diseases Figure 1. The weekly proportion of influenza-like illness visits per 1,000 patients from 2008-2009 season to 2012-2013 season Figure 1. The status of HFMD sentinel surveillance, 2010-2013 Figure 1. The mean of patient visits to sentinel physicians for Epidemic keratoconjunctivitis by week, 2010-2013 Figure 2. The mean of patient visits to sentinel physicians for A cute hemorrhagic conjunctivitis by week, 2010-2013

478 PUBLIC HEALTH WEEKLY REPORT, KCDC Table 1. Provisional cases of reported notifiable diseases-republic of Korea, week ending Jun 8, 2013(23th week) -: No reported cases. Cum: Cumulative counts of the year from 1st week to current week. EHEC: Enterohemorrhagic Escherichia coli. HFRS: Hemorrhagic fever with renal syndrome. CJD/vCJD: Creutzfeldt-Jacob Disease / variant Creutzfeldt-Jacob Disease. * Incidence data for reporting year 2012, 2013 is provisional, whereas data for 2008, 2009, 2010 and 2011 are finalized. Reported cases contain all case classifications(confirmed, Suspected, Asymptomatic carrier) of the disease respectively. Excluding Hansen's disease, diseases reported through the Sentinel Surveillance System(Data for Sentinel Surveillance System are available in Table III), and diseases no case reported(diphtheria, Poliomyelitis, Epidemic typhus, Anthrax, Plague, Yellow fever,viral hemorrhagic fever, Smallpox, Severe Acute Respiratory Syndrome, Avian influenza infection and humans, Novel Influenza, Tularemia, Newly emerging infectious disease syndrome, Tick-borne Encephalitis, Chikungunya fever) Surveillance system for Viral hepatitis A, Viral hepatitis B, Syphilis, CJD/vCJD, West Nile fever was altered from Sentinel Surveillance System to National Infectious Disease Surveillance System as of December 30,2010. Calculated by summing the incidence counts for the current week, the 2 weeks preceding the current week, and the 2 weeks following the current week, for a total of 5 preceding years(for Viral hepatitis A, Viral hepatitis B, Syphilis, CJD/vCJD, West Nile fever, Lyme Borreliosis, Melioidosis, this calculation used 2 year data(2011, 2012) only, because of being designated as of December 30,2010). **Viral hepatitis B comprises acute Viral hepatitis B, HBsAg positive maternity, Perinatal hepatitis B virus infection. Scarlet fever's case classifications added suspected cases in addition to confirmed cases. Cases who have not Korean citizenship were excluded.

www.cdc.go.kr 479 Table 2. Provisional cases of selected notifiable diseases, Republic of Korea, weeks ending Jun 8, 2013(23th week) -: No reported cases. Cum: Cumulative counts of the year from 1st week to current week. * Incidence data for reporting years 2012, 2013 is provisional, whereas data for 2008, 2009, 2010 and 2011 are finalized. Reported cases contain all case classifications (Confirmed, Suspected, Asymptomatic carrier) of the disease, respectively. Surveillance system for Viral hepatitis A was altered from Sentinel Surveillance System to National Infectious Disease Surveillance System as of December 30,2010. Calculated by averaging the cumulative counts from 1st week to current week, for a total of 5 preceding years.

480 Table 2. Provisional cases of selected notifiable diseases, Republic of Korea, weeks ending Jun 8, 2013(23th week) -: No reported cases. Cum: Cumulative counts of the year from 1st week to current week. * Incidence data for reporting years 2012, 2013 is provisional, whereas data for 2008, 2009, 2010 and 2011 are finalized. Reported cases contain all case classifications (Confirmed, Suspected, Asymptomatic carrier) of the disease, respectively. Surveillance system for Viral hepatitis A was altered from Sentinel Surveillance System to National Infectious Disease Surveillance System as of December 30,2010. Calculated by averaging the cumulative counts from 1st week to current week, for a total of 5 preceding years. Scarlet fever's case classifications added suspected cases in addition to confirmed cases.

www.cdc.go.kr 481 Table 2. Provisional cases of selected notifiable diseases, Republic of Korea, weeks ending Jun 8, 2013(23th week) -: No reported cases. Cum: Cumulative counts of the year from 1st week to current week. * Incidence data for reporting years2012, 2013 is provisional, whereas data for 2008, 2009, 2010 and 2011 are finalized. Reported cases contain all case classifications (Confirmed, Suspected, Asymptomatic carrier) of the disease, respectively. Calculated by averaging the cumulative counts from 1st week to current week, for a total of 5 preceding years.

482 Table 2. Provisional cases of selected notifiable diseases, Republic of Korea, weeks ending Jun 8, 2013(23th week) -: No reported cases. Cum: Cumulative counts of the year from 1st week to current week. * Incidence data for reporting years 2012, 2013 is provisional, whereas data for 2008, 2009, 2010 and 2011 are finalized. Reported cases contain all case classifications (Confirmed, Suspected, Asymptomatic carrier) of the disease, respectively. Surveillance system for Syphilis, CJD/vCJD was altered from Sentinel Surveillance System to National Infectious Disease Surveillance System as of December 30,2010. Calculated by averaging the cumulative counts from 1st week to current week, for a total of 5 preceding years.

www.cdc.go.kr 483 Table 3. Provisional cases of reported sentinel surveillance disease, Republic of Korea, weeks ending June 1, 2013(22nd week) -: No reported cases. Cum: Cumulative counts of the year from 1st week to current week. * Above data for reporting years 2012 and 2013 are provisional. Reported cases contain all case classifications (Confirmed, Suspected, Asymptomatic carrier) of the disease, respectively. Calculated by averaging the cumulative counts from 1st week to current week, for a total of 5 preceding *

www.cdc.go.kr PUBLIC HEALTH WEEKLY REPORT, KCDC 363-951 Tel. (043)719-7168, 7164Fax. (043)719-7189http://www.cdc.go.kr